Prostate Cancer The Gabrail Cancer Center currently has many Clinical Trial opportunities . For more information and to see if you qualify call Carrie Smith R.N., Director of Research at 330-492-3345 x 208 orĀ via email CSmith@GabrailCancerCenter.com. A Phase 1b/2 Study to Evaluate the Safety and Tolerability of VERU111 in Men with Advanced Metastatic Castration Resistant Prostate Cancer An Open-label, Nonrandomized, Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Belinostat in Patients with Relapsed/Refractory Solid Tumors or Hematological Malignancies Who Have Wild-Type, Heterozygous, and Homozygous UGT1A1*28 Genotypes Return to Clinical Trials at GCC